Novo Holdings invests in life science and bio-sustainability solutions to improve human health and environmental sustainability, generating attractive long-term returns for the Novo Nordisk Foundation. The firm emphasizes responsible investing, societal impact, and diversified capital allocation across multiple asset classes.
Preferred startup development maturity for initial funding deployment.
Life science companies, equities, bonds, real estate, infrastructure, and private equity investments with a focus on long-term value creation and sustainability.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
